Serveur d'exploration sur la grippe en Allemagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study.

Identifieur interne : 000231 ( Main/Exploration ); précédent : 000230; suivant : 000232

Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study.

Auteurs : Martin Feuchtenberger [Allemagne] ; Stefan Kleinert ; Sven Schwab ; Petra Roll ; Eva Christina Scharbatke ; Eva Ostermeier ; Reinhard E. Voll ; Arne Sch Fer ; Hans-Peter Tony

Source :

RBID : pubmed:21327432

Descripteurs français

English descriptors

Abstract

The objective of this study is to evaluate the vaccination status in rheumatoid arthritis (RA) patients during routine clinical practice, data from a German non-interventional cross-sectional study. In this prospective study, patients with rheumatoid arthritis were interviewed using a standardized questionnaire focusing on vaccination. Available vaccination documents were evaluated, and titers for common vaccination antigens (hepatitis B, rubella, mumps, measles, diphtheria, tetanus) were analyzed with special regard to the underlying treatment and age of patients. A total of 301 RA patients treated with conventional DMARDs alone (cohort I, n = 125), TNF-blocking agents (cohort II, n = 117), or B-cell depletion with rituximab (cohort III, n = 59) have been studied. Significantly more patients in the biologic cohorts II and III were aware of an increased risk of infections (I: 67.7%, II: 83.8%*, III: 89.9%*, P < 0.05). Pneumococcal vaccination rate was significantly higher (I: 20.2%, II 36.8%* and III: 39.0%*, P < 0.05) compared with cohort I. Differences were less evident for influenza. Significantly more patients ≥60 years of age have been vaccinated against Streptococcus pneumoniae and influenza. An obvious discrepancy existed between vaccination awareness and actual vaccination rates for all cohorts. No significant differences in vaccination titers could be seen between the three cohorts. Awareness of infectious complications was more present in patients treated with biologicals, and also, the rate of patients vaccinated against Streptococcus pneumoniae increased significantly depending on the underlying treatment. Nevertheless, there was a discrepancy between vaccination awareness and actual vaccination rates for all cohorts.

DOI: 10.1007/s00296-011-1808-z
PubMed: 21327432


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study.</title>
<author>
<name sortKey="Feuchtenberger, Martin" sort="Feuchtenberger, Martin" uniqKey="Feuchtenberger M" first="Martin" last="Feuchtenberger">Martin Feuchtenberger</name>
<affiliation wicri:level="3">
<nlm:affiliation>Medizinische Klinik, Universität Wuerzburg, Schwerpunkt Rheumatologie/Klinische Immunologie, Oberdürrbacherstrasse 6, 97080, Wuerzburg, Germany. Feuchtenbe_M@klinik.uni-wuerzburg.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medizinische Klinik, Universität Wuerzburg, Schwerpunkt Rheumatologie/Klinische Immunologie, Oberdürrbacherstrasse 6, 97080, Wuerzburg</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Basse-Franconie</region>
<settlement type="city">Wurtzbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kleinert, Stefan" sort="Kleinert, Stefan" uniqKey="Kleinert S" first="Stefan" last="Kleinert">Stefan Kleinert</name>
</author>
<author>
<name sortKey="Schwab, Sven" sort="Schwab, Sven" uniqKey="Schwab S" first="Sven" last="Schwab">Sven Schwab</name>
</author>
<author>
<name sortKey="Roll, Petra" sort="Roll, Petra" uniqKey="Roll P" first="Petra" last="Roll">Petra Roll</name>
</author>
<author>
<name sortKey="Scharbatke, Eva Christina" sort="Scharbatke, Eva Christina" uniqKey="Scharbatke E" first="Eva Christina" last="Scharbatke">Eva Christina Scharbatke</name>
</author>
<author>
<name sortKey="Ostermeier, Eva" sort="Ostermeier, Eva" uniqKey="Ostermeier E" first="Eva" last="Ostermeier">Eva Ostermeier</name>
</author>
<author>
<name sortKey="Voll, Reinhard E" sort="Voll, Reinhard E" uniqKey="Voll R" first="Reinhard E" last="Voll">Reinhard E. Voll</name>
</author>
<author>
<name sortKey="Sch Fer, Arne" sort="Sch Fer, Arne" uniqKey="Sch Fer A" first="Arne" last="Sch Fer">Arne Sch Fer</name>
</author>
<author>
<name sortKey="Tony, Hans Peter" sort="Tony, Hans Peter" uniqKey="Tony H" first="Hans-Peter" last="Tony">Hans-Peter Tony</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:21327432</idno>
<idno type="pmid">21327432</idno>
<idno type="doi">10.1007/s00296-011-1808-z</idno>
<idno type="wicri:Area/Main/Corpus">000299</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000299</idno>
<idno type="wicri:Area/Main/Curation">000299</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000299</idno>
<idno type="wicri:Area/Main/Exploration">000299</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study.</title>
<author>
<name sortKey="Feuchtenberger, Martin" sort="Feuchtenberger, Martin" uniqKey="Feuchtenberger M" first="Martin" last="Feuchtenberger">Martin Feuchtenberger</name>
<affiliation wicri:level="3">
<nlm:affiliation>Medizinische Klinik, Universität Wuerzburg, Schwerpunkt Rheumatologie/Klinische Immunologie, Oberdürrbacherstrasse 6, 97080, Wuerzburg, Germany. Feuchtenbe_M@klinik.uni-wuerzburg.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medizinische Klinik, Universität Wuerzburg, Schwerpunkt Rheumatologie/Klinische Immunologie, Oberdürrbacherstrasse 6, 97080, Wuerzburg</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Basse-Franconie</region>
<settlement type="city">Wurtzbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kleinert, Stefan" sort="Kleinert, Stefan" uniqKey="Kleinert S" first="Stefan" last="Kleinert">Stefan Kleinert</name>
</author>
<author>
<name sortKey="Schwab, Sven" sort="Schwab, Sven" uniqKey="Schwab S" first="Sven" last="Schwab">Sven Schwab</name>
</author>
<author>
<name sortKey="Roll, Petra" sort="Roll, Petra" uniqKey="Roll P" first="Petra" last="Roll">Petra Roll</name>
</author>
<author>
<name sortKey="Scharbatke, Eva Christina" sort="Scharbatke, Eva Christina" uniqKey="Scharbatke E" first="Eva Christina" last="Scharbatke">Eva Christina Scharbatke</name>
</author>
<author>
<name sortKey="Ostermeier, Eva" sort="Ostermeier, Eva" uniqKey="Ostermeier E" first="Eva" last="Ostermeier">Eva Ostermeier</name>
</author>
<author>
<name sortKey="Voll, Reinhard E" sort="Voll, Reinhard E" uniqKey="Voll R" first="Reinhard E" last="Voll">Reinhard E. Voll</name>
</author>
<author>
<name sortKey="Sch Fer, Arne" sort="Sch Fer, Arne" uniqKey="Sch Fer A" first="Arne" last="Sch Fer">Arne Sch Fer</name>
</author>
<author>
<name sortKey="Tony, Hans Peter" sort="Tony, Hans Peter" uniqKey="Tony H" first="Hans-Peter" last="Tony">Hans-Peter Tony</name>
</author>
</analytic>
<series>
<title level="j">Rheumatology international</title>
<idno type="eISSN">1437-160X</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Analysis of Variance (MeSH)</term>
<term>Antirheumatic Agents (adverse effects)</term>
<term>Antirheumatic Agents (therapeutic use)</term>
<term>Arthritis, Rheumatoid (drug therapy)</term>
<term>Arthritis, Rheumatoid (immunology)</term>
<term>Awareness (MeSH)</term>
<term>Bacterial Infections (immunology)</term>
<term>Bacterial Infections (microbiology)</term>
<term>Bacterial Infections (prevention & control)</term>
<term>Bacterial Vaccines (administration & dosage)</term>
<term>Bacterial Vaccines (adverse effects)</term>
<term>Communicable Disease Control (methods)</term>
<term>Cross-Sectional Studies (MeSH)</term>
<term>Diphtheria-Tetanus Vaccine (MeSH)</term>
<term>Germany (MeSH)</term>
<term>Health Care Surveys (MeSH)</term>
<term>Health Knowledge, Attitudes, Practice (MeSH)</term>
<term>Hepatitis B Vaccines (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza Vaccines (MeSH)</term>
<term>Measles-Mumps-Rubella Vaccine (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pneumococcal Vaccines (MeSH)</term>
<term>Prospective Studies (MeSH)</term>
<term>Risk Assessment (MeSH)</term>
<term>Risk Factors (MeSH)</term>
<term>Surveys and Questionnaires (MeSH)</term>
<term>Vaccination (adverse effects)</term>
<term>Viral Vaccines (administration & dosage)</term>
<term>Viral Vaccines (adverse effects)</term>
<term>Virus Diseases (immunology)</term>
<term>Virus Diseases (microbiology)</term>
<term>Virus Diseases (prevention & control)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen (MeSH)</term>
<term>Allemagne (MeSH)</term>
<term>Analyse de variance (MeSH)</term>
<term>Antirhumatismaux (effets indésirables)</term>
<term>Antirhumatismaux (usage thérapeutique)</term>
<term>Appréciation des risques (MeSH)</term>
<term>Connaissances, attitudes et pratiques en santé (MeSH)</term>
<term>Conscience immédiate (MeSH)</term>
<term>Contrôle des maladies transmissibles (méthodes)</term>
<term>Enquêtes et questionnaires (MeSH)</term>
<term>Enquêtes sur les soins de santé (MeSH)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections bactériennes (immunologie)</term>
<term>Infections bactériennes (microbiologie)</term>
<term>Infections bactériennes (prévention et contrôle)</term>
<term>Maladies virales (immunologie)</term>
<term>Maladies virales (microbiologie)</term>
<term>Maladies virales (prévention et contrôle)</term>
<term>Polyarthrite rhumatoïde (immunologie)</term>
<term>Polyarthrite rhumatoïde (traitement médicamenteux)</term>
<term>Vaccin antidiphtérique antitétanique (MeSH)</term>
<term>Vaccin contre la rougeole, les oreillons et la rubéole (MeSH)</term>
<term>Vaccination (effets indésirables)</term>
<term>Vaccins anti-hépatite B (MeSH)</term>
<term>Vaccins antibactériens (administration et posologie)</term>
<term>Vaccins antibactériens (effets indésirables)</term>
<term>Vaccins antigrippaux (MeSH)</term>
<term>Vaccins antipneumococciques (MeSH)</term>
<term>Vaccins antiviraux (administration et posologie)</term>
<term>Vaccins antiviraux (effets indésirables)</term>
<term>Études prospectives (MeSH)</term>
<term>Études transversales (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Bacterial Vaccines</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antirheumatic Agents</term>
<term>Bacterial Vaccines</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antirheumatic Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Germany</term>
<term>Hepatitis B Vaccines</term>
<term>Influenza Vaccines</term>
<term>Measles-Mumps-Rubella Vaccine</term>
<term>Pneumococcal Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Vaccins antibactériens</term>
<term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Arthritis, Rheumatoid</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Antirhumatismaux</term>
<term>Vaccination</term>
<term>Vaccins antibactériens</term>
<term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Infections bactériennes</term>
<term>Maladies virales</term>
<term>Polyarthrite rhumatoïde</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Arthritis, Rheumatoid</term>
<term>Bacterial Infections</term>
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Communicable Disease Control</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Infections bactériennes</term>
<term>Maladies virales</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Bacterial Infections</term>
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Contrôle des maladies transmissibles</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Bacterial Infections</term>
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Infections bactériennes</term>
<term>Maladies virales</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Polyarthrite rhumatoïde</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antirhumatismaux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Analysis of Variance</term>
<term>Awareness</term>
<term>Cross-Sectional Studies</term>
<term>Diphtheria-Tetanus Vaccine</term>
<term>Health Care Surveys</term>
<term>Health Knowledge, Attitudes, Practice</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Risk Assessment</term>
<term>Risk Factors</term>
<term>Surveys and Questionnaires</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Allemagne</term>
<term>Analyse de variance</term>
<term>Appréciation des risques</term>
<term>Connaissances, attitudes et pratiques en santé</term>
<term>Conscience immédiate</term>
<term>Enquêtes et questionnaires</term>
<term>Enquêtes sur les soins de santé</term>
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Vaccin antidiphtérique antitétanique</term>
<term>Vaccin contre la rougeole, les oreillons et la rubéole</term>
<term>Vaccins anti-hépatite B</term>
<term>Vaccins antigrippaux</term>
<term>Vaccins antipneumococciques</term>
<term>Études prospectives</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The objective of this study is to evaluate the vaccination status in rheumatoid arthritis (RA) patients during routine clinical practice, data from a German non-interventional cross-sectional study. In this prospective study, patients with rheumatoid arthritis were interviewed using a standardized questionnaire focusing on vaccination. Available vaccination documents were evaluated, and titers for common vaccination antigens (hepatitis B, rubella, mumps, measles, diphtheria, tetanus) were analyzed with special regard to the underlying treatment and age of patients. A total of 301 RA patients treated with conventional DMARDs alone (cohort I, n = 125), TNF-blocking agents (cohort II, n = 117), or B-cell depletion with rituximab (cohort III, n = 59) have been studied. Significantly more patients in the biologic cohorts II and III were aware of an increased risk of infections (I: 67.7%, II: 83.8%*, III: 89.9%*, P < 0.05). Pneumococcal vaccination rate was significantly higher (I: 20.2%, II 36.8%* and III: 39.0%*, P < 0.05) compared with cohort I. Differences were less evident for influenza. Significantly more patients ≥60 years of age have been vaccinated against Streptococcus pneumoniae and influenza. An obvious discrepancy existed between vaccination awareness and actual vaccination rates for all cohorts. No significant differences in vaccination titers could be seen between the three cohorts. Awareness of infectious complications was more present in patients treated with biologicals, and also, the rate of patients vaccinated against Streptococcus pneumoniae increased significantly depending on the underlying treatment. Nevertheless, there was a discrepancy between vaccination awareness and actual vaccination rates for all cohorts.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21327432</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>12</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1437-160X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>32</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2012</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Rheumatology international</Title>
<ISOAbbreviation>Rheumatol. Int.</ISOAbbreviation>
</Journal>
<ArticleTitle>Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study.</ArticleTitle>
<Pagination>
<MedlinePgn>1533-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-011-1808-z</ELocationID>
<Abstract>
<AbstractText>The objective of this study is to evaluate the vaccination status in rheumatoid arthritis (RA) patients during routine clinical practice, data from a German non-interventional cross-sectional study. In this prospective study, patients with rheumatoid arthritis were interviewed using a standardized questionnaire focusing on vaccination. Available vaccination documents were evaluated, and titers for common vaccination antigens (hepatitis B, rubella, mumps, measles, diphtheria, tetanus) were analyzed with special regard to the underlying treatment and age of patients. A total of 301 RA patients treated with conventional DMARDs alone (cohort I, n = 125), TNF-blocking agents (cohort II, n = 117), or B-cell depletion with rituximab (cohort III, n = 59) have been studied. Significantly more patients in the biologic cohorts II and III were aware of an increased risk of infections (I: 67.7%, II: 83.8%*, III: 89.9%*, P < 0.05). Pneumococcal vaccination rate was significantly higher (I: 20.2%, II 36.8%* and III: 39.0%*, P < 0.05) compared with cohort I. Differences were less evident for influenza. Significantly more patients ≥60 years of age have been vaccinated against Streptococcus pneumoniae and influenza. An obvious discrepancy existed between vaccination awareness and actual vaccination rates for all cohorts. No significant differences in vaccination titers could be seen between the three cohorts. Awareness of infectious complications was more present in patients treated with biologicals, and also, the rate of patients vaccinated against Streptococcus pneumoniae increased significantly depending on the underlying treatment. Nevertheless, there was a discrepancy between vaccination awareness and actual vaccination rates for all cohorts.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Feuchtenberger</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Medizinische Klinik, Universität Wuerzburg, Schwerpunkt Rheumatologie/Klinische Immunologie, Oberdürrbacherstrasse 6, 97080, Wuerzburg, Germany. Feuchtenbe_M@klinik.uni-wuerzburg.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kleinert</LastName>
<ForeName>Stefan</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schwab</LastName>
<ForeName>Sven</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Roll</LastName>
<ForeName>Petra</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Scharbatke</LastName>
<ForeName>Eva Christina</ForeName>
<Initials>EC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ostermeier</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Voll</LastName>
<ForeName>Reinhard E</ForeName>
<Initials>RE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schäfer</LastName>
<ForeName>Arne</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tony</LastName>
<ForeName>Hans-Peter</ForeName>
<Initials>HP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>02</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Rheumatol Int</MedlineTA>
<NlmUniqueID>8206885</NlmUniqueID>
<ISSNLinking>0172-8172</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001428">Bacterial Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D022422">Diphtheria-Tetanus Vaccine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017325">Hepatitis B Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D022542">Measles-Mumps-Rubella Vaccine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001364" MajorTopicYN="N">Awareness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001428" MajorTopicYN="N">Bacterial Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022422" MajorTopicYN="N">Diphtheria-Tetanus Vaccine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017325" MajorTopicYN="N">Hepatitis B Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022542" MajorTopicYN="N">Measles-Mumps-Rubella Vaccine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2010</Year>
<Month>10</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2011</Year>
<Month>01</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>2</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>2</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>12</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21327432</ArticleId>
<ArticleId IdType="doi">10.1007/s00296-011-1808-z</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Ann Rheum Dis. 2007 Oct;66(10):1402-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17881666</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2010 Jan;62(1):64-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20039397</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2006 May;54(5):1390-400</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16649186</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autoimmunity. 2005 Jun;38(4):295-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16206512</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2009 Nov 15;61(11):1505-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19877088</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rheumatology (Oxford). 2007 Jul;46(7):1157-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17478469</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2006 Sep;54(9):2793-806</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16947627</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Arthritis Rheum. 1999 Dec;29(3):131-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10622677</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2005 Nov;52(11):3403-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16255017</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Rheumatol. 2010 Mar;37(3):558-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20110520</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2006 Dec 14;355(24):2513-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17167134</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rheumatology (Oxford). 2006 Jan;45(1):106-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16287919</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2008 Jul;67(7):937-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17981914</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2001 Sep 14;19(32):4780-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11535330</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mech Ageing Dev. 2009 Sep;130(9):564-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19632262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2007 Jan 8;167(1):53-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17210878</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rheumatology (Oxford). 2010 Oct;49(10):1815-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20591834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Infect Dis. 2004 Jun;17(3):177-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15166818</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2002 Sep;46(9):2287-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12355475</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2010 Jan;62(1):75-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20039396</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rheumatology (Oxford). 2009 Feb;48(2):144-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19074187</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2008 May;67(5):713-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17965123</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rheumatology (Oxford). 2006 Jul;45(7):912-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16638800</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Immunol. 2007 Jan;122(1):62-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17046329</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
<region>
<li>Bavière</li>
<li>District de Basse-Franconie</li>
</region>
<settlement>
<li>Wurtzbourg</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Kleinert, Stefan" sort="Kleinert, Stefan" uniqKey="Kleinert S" first="Stefan" last="Kleinert">Stefan Kleinert</name>
<name sortKey="Ostermeier, Eva" sort="Ostermeier, Eva" uniqKey="Ostermeier E" first="Eva" last="Ostermeier">Eva Ostermeier</name>
<name sortKey="Roll, Petra" sort="Roll, Petra" uniqKey="Roll P" first="Petra" last="Roll">Petra Roll</name>
<name sortKey="Sch Fer, Arne" sort="Sch Fer, Arne" uniqKey="Sch Fer A" first="Arne" last="Sch Fer">Arne Sch Fer</name>
<name sortKey="Scharbatke, Eva Christina" sort="Scharbatke, Eva Christina" uniqKey="Scharbatke E" first="Eva Christina" last="Scharbatke">Eva Christina Scharbatke</name>
<name sortKey="Schwab, Sven" sort="Schwab, Sven" uniqKey="Schwab S" first="Sven" last="Schwab">Sven Schwab</name>
<name sortKey="Tony, Hans Peter" sort="Tony, Hans Peter" uniqKey="Tony H" first="Hans-Peter" last="Tony">Hans-Peter Tony</name>
<name sortKey="Voll, Reinhard E" sort="Voll, Reinhard E" uniqKey="Voll R" first="Reinhard E" last="Voll">Reinhard E. Voll</name>
</noCountry>
<country name="Allemagne">
<region name="Bavière">
<name sortKey="Feuchtenberger, Martin" sort="Feuchtenberger, Martin" uniqKey="Feuchtenberger M" first="Martin" last="Feuchtenberger">Martin Feuchtenberger</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000231 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000231 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeAllemagneV4
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21327432
   |texte=   Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21327432" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV4 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 17:53:30 2020. Site generation: Sat Mar 27 17:40:37 2021